BiotechTube
Home/NovAccess Global/Dr. Dwain Irvin, Ph.D., MPH
DD

Dr. Dwain Irvin, Ph.D., MPH

CEO, CFO, Executive Board Member

NovAccess Global

Therapeutic Areas

OncologyNeurology

NovAccess Global Pipeline

DrugIndicationPhase
TLR-AD1Glioblastoma Multiforme (GBM)Pre-IND

Leadership Team at NovAccess Global

DC
Dr. Christopher Wheeler, Ph.D.
President, StemVax Therapeutics Inc.
View full NovAccess Global profile